Literature DB >> 15286678

Inter-device reproducibility of the scanning laser polarimeter with variable cornea compensation.

E Z Blumenthal1, S Frenkel.   

Abstract

OBJECTIVE: To evaluate the interdevice reproducibility of retinal nerve fibre layer (RNFL) thickness measurements obtained with the commercially available GDx-VCC, a scanning laser polarimeter with variable (individualized) corneal compensation.
METHODS: A prospective instrument validation study in which 13 GDx-VCC devices were tested. One eye each, from three normal subjects were used to test each of the devices, on the same day, by an experienced operator. Variability and reproducibility for each of five GDx parameters were calculated.
RESULTS: For each of five tested GDx parameters, the coefficient of variation and 95% confidence interval range (microm), for the 13 devices, respectively, were: TSNIT avg: 5.1%, 3.84 microm; Superior avg: 5.3%, 4.82 microm; Inferior avg: 6.1%, 5.50 microm; TSNIT standard deviation: 8.6%, 2.92 microm; and nerve fibre indicator (NFI): N/A, 5.69. Item reliability (Cronbach's alpha) for the five GDx parameters are: TSNIT-Avg: 0.97, Sup-Avg: 1.00, Inf-Avg: 0.84, TSNIT-SD: 0.99, NFI: 0.99.
CONCLUSIONS: With the commercially available GDx-VCC, our results indicate that RNFL measurements appear reproducible across devices.

Entities:  

Mesh:

Year:  2005        PMID: 15286678     DOI: 10.1038/sj.eye.6701472

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  2 in total

Review 1.  Test-retest variability in structural parameters measured with glaucoma imaging devices.

Authors:  Makoto Araie
Journal:  Jpn J Ophthalmol       Date:  2012-11-09       Impact factor: 2.447

2.  Optical coherence tomography-measured retinal nerve fiber layer thickness values compensated with a multivariate model and discrimination between stable and progressing glaucoma suspects.

Authors:  Hemma Resch; Florian Schwarzhans; Florian Frommlet; Anton Hommer; Philipp Fuchs; Clemens Vass
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-08-05       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.